Neonc Technologies Holdings, Inc. (NASDAQ: NTHI) is a Healthcare company (Biotechnology) with a market capitalization of $125M. The Maz Rating grades it against the other companies in its sector.
Neonc Technologies Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
Neonc Technologies Holdings, Inc. has been loss-making over the last twelve months, so it has no meaningful P/E. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of 349.3%, return on invested capital of 316.1% and a free cash flow yield of -16.4%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 0.38. Over the past 52 weeks the share price ranged from $2.50 to $11.38, with a beta of 0.50.
Neonc Technologies Holdings, Inc. does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Neonc Technologies Holdings, Inc. (NTHI) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 6.79% / 30% · Interest income / Revenue 1541200.0% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 6.79% / 33% · Receivables / Mkt Cap (36m) 0.00% / 49% · Interest income / Revenue 1541200.0% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 6.79% / 33.33% · Receivables / Mkt Cap (24m) 0.00% / 33.33% · Interest income / Revenue 1541200.0% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 29.5% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 40.3% / 33.33% · Receivables / Avg Assets (4Q) 1.34% / 33.33% · Interest income / Revenue 1541200.0% / 5% | Fail |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 66.3% / 33.33% · (Cash+Recv) / Total Assets 66.3% / 33.33% · Interest income / Revenue 1541200.0% / 5% | Fail |
No. As of September 2026, Neonc Technologies Holdings, Inc. (NTHI) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Neonc Technologies Holdings, Inc. is over the AAOIFI limit on Interest income / Revenue.
About 1541200.0% of each dividend: Neonc Technologies Holdings, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.